Detalles de la búsqueda
1.
Long-term safety and efficacy of pegunigalsidase alfa: A multicenter 6-year study in adult patients with Fabry disease.
Genet Med
; 25(12): 100968, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37634127
2.
Pegunigalsidase alfa, a novel PEGylated enzyme replacement therapy for Fabry disease, provides sustained plasma concentrations and favorable pharmacodynamics: A 1-year Phase 1/2 clinical trial.
J Inherit Metab Dis
; 42(3): 534-544, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30834538
3.
Treatment-naïve Gaucher disease patients achieve therapeutic goals and normalization with velaglucerase alfa by 4years in phase 3 trials.
Blood Cells Mol Dis
; 68: 153-159, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27839979
4.
Development of anti-velaglucerase alfa antibodies in clinical trial-treated patients with Gaucher disease.
Blood Cells Mol Dis
; 59: 37-43, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27282565
5.
Velaglucerase alfa (VPRIV) enzyme replacement therapy in patients with Gaucher disease: Long-term data from phase III clinical trials.
Am J Hematol
; 90(7): 584-91, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25801797
6.
Enzyme replacement therapy with velaglucerase alfa in Gaucher disease: Results from a randomized, double-blind, multinational, Phase 3 study.
Am J Hematol
; 88(3): 166-71, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23386328
7.
Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease.
Am J Hematol
; 88(3): 179-84, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23400823
8.
Response to request by journal editorship from Blood Cells, Molecules and Diseases in reference to a "Dear Editor" letter to the Pastores et al. paper, 2016.
Blood Cells Mol Dis
; 65: 71-72, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28576608
9.
Rituximab biosimilar RTXM83 versus reference rituximab in combination with CHOP as first-line treatment for diffuse large B-cell lymphoma: a randomized, double-blind study.
Leuk Lymphoma
; 60(14): 3375-3385, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31272251
10.
Comparative assessment of pharmacokinetics, and pharmacodynamics between RTXM83™, a rituximab biosimilar, and rituximab in diffuse large B-cell lymphoma patients: a population PK model approach.
Cancer Chemother Pharmacol
; 81(3): 515-527, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29362903
11.
Citomegalovirus en pacientes inmunocomprometidos detectados por PCR en Paraguay del 2008 a 2015
Rev. virtual Soc. Parag. Med. Int
; 3(2)sept. 2016.
Artículo
en Español
|
LILACS-Express
| ID: biblio-1390107
Resultados
1 -
11
de 11
1
Próxima >
>>